Hepatitis C risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(15 intermediate revisions by 8 users not shown)
Line 1: Line 1:
{{#widget:SchemaSnippet}}
__NOTOC__
{{Hepatitis C}}
{{Hepatitis C}}
{{CMG}} '''Associate Editor(s)-In-Chief:''' [[User:YazanDaaboul|Yazan Daaboul]]; [[User:Sergekorjian|Serge Korjian]]
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[User:YazanDaaboul|Yazan Daaboul]], [[User:Sergekorjian|Serge Korjian]];{{JA}}
==Overview==
==Overview==
The most important mode of HCV transmission is percutaneous blood exposure. Intravenous drug use is currently considered the most important risk factor for HCV infection. Populations at highest risk of HCV infection are those who have received blood and blood products, especially before 1992, and those who have received unsafe therapeutic injections.
The most potent [[risk factor]] in the development of hepatitis C is [[intravenous drug use]]. Other [[risk factors]] include occupational exposure to [[blood]], sexual intercourse with infected individuals, multiple [[bloods]] [[transfusions]] prior to 1992, and [[HIV]] [[infection]].


==Risk Factors==
==Risk Factors==
Percutaneous exposure to blood is the most important mode of HCV transmission.
Percutaneous exposure to [[blood]] is the primary mode of HCV transmission.
The following are the most important risk factors for HCV infection<ref name="pmid17552026">{{cite journal| author=Alter MJ| title=Epidemiology of hepatitis C virus infection. | journal=World J Gastroenterol | year= 2007 | volume= 13 | issue= 17 | pages= 2436-41 | pmid=17552026 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17552026  }} </ref>:
The following are the most important [[risk factors]] for HCV [[infection]]:<ref name="pmid17552026">{{cite journal| author=Alter MJ| title=Epidemiology of hepatitis C virus infection. | journal=World J Gastroenterol | year= 2007 | volume= 13 | issue= 17 | pages= 2436-41 | pmid=17552026 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17552026  }} </ref><ref name="Kaplan2020">{{cite journal|last1=Kaplan|first1=David E.|title=Hepatitis C Virus|journal=Annals of Internal Medicine|volume=173|issue=5|year=2020|pages=ITC33–ITC48|issn=0003-4819|doi=10.7326/AITC202009010}}</ref>:
*'''Injecting drug use''' is nowadays the most important risk factor
* Individuals are majorly infected via [[percutaneous]] exposure to infected [[blood]]. Most persons with HCV were [[infected]].
*'''Transfusion of blood and blood products''', especially before 1992
*'''Injecting drug use''' is the most important [[risk factors]] nowadays
*'''Unsafe therapeutic injections''', especially in Hemophilia patients before 1987
*'''Transfusion of [[blood]] and blood products''', especially before 1992
*'''Unsafe therapeutic injections''', especially in [[hemophilia]] patients prior to 1987


Other less important risk factors are<ref name="pmid17552026">{{cite journal| author=Alter MJ| title=Epidemiology of hepatitis C virus infection. | journal=World J Gastroenterol | year= 2007 | volume= 13 | issue= 17 | pages= 2436-41 | pmid=17552026 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17552026  }} </ref>:
Other, less important risk factors include:<ref name="pmid17552026">{{cite journal| author=Alter MJ| title=Epidemiology of hepatitis C virus infection. | journal=World J Gastroenterol | year= 2007 | volume= 13 | issue= 17 | pages= 2436-41 | pmid=17552026 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17552026  }} </ref><ref name="Kaplan2020">{{cite journal|last1=Kaplan|first1=David E.|title=Hepatitis C Virus|journal=Annals of Internal Medicine|volume=173|issue=5|year=2020|pages=ITC33–ITC48|issn=0003-4819|doi=10.7326/AITC202009010}}</ref>
*[[Hemodialysis]]
*[[Hemodialysis]] (Higher rates of infection are observed)
*Solid organ [[transplantation]] from infected donors
*Solid organ [[transplantation]] from infected donors
*Occupational exposure to blood, such as contaminated needle sticks
*Occupational exposure to blood, such as contaminated needle sticks
*Birth to infected mother in cases of detectable maternal [[HCV PCR]] at [[delivery]]
*Birth to infected mother in cases of detectable maternal [[HCV PCR]] at [[delivery]] (at the rate of 4%–5%). [[Breastfeeding]] is not associated with the [[transmission]].
*Sexual intercourse with infected partner
*Sexual intercourse with infected partner
*Sexual intercourse with multiple partners
*Sexual intercourse with multiple partners
*[[HIV]] infection
*[[HIV]] infection
*[[Tattoo]] or [[piercing]] with infected needle sticks
*[[Tattoo]] or piercing with infected needle sticks (low risk for transmission after strict infection control measures)
 
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}


[[Category:Hepatitis|C]]
 
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:FinalQCRequired]]
[[Category:Emergency mdicine]]
[[Category:Disease]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]
[[Category:Infectious disease]]
[[Category:Disease]]
[[Category:Hepatology]]
 
{{WH}}
{{WS}}

Latest revision as of 03:33, 11 June 2021

Hepatitis Main Page

Hepatitis C

Home

Patient Info

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology & Demographics

Risk Factors

Screening

Differentiating Hepatitis C from other Diseases

Natural History, Complications & Prognosis

Diagnosis

History & Symptoms

Physical Examination

Lab Tests

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Hepatitis C risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatitis C risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatitis C risk factors

CDC on Hepatitis C risk factors

Hepatitis C risk factors in the news

Blogs on Hepatitis C risk factors

Directions to Hospitals Treating Hepatitis C

Risk calculators and risk factors for Hepatitis C risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Yazan Daaboul, Serge Korjian;Javaria Anwer M.D.[2]

Overview

The most potent risk factor in the development of hepatitis C is intravenous drug use. Other risk factors include occupational exposure to blood, sexual intercourse with infected individuals, multiple bloods transfusions prior to 1992, and HIV infection.

Risk Factors

Percutaneous exposure to blood is the primary mode of HCV transmission. The following are the most important risk factors for HCV infection:[1][2]:

  • Individuals are majorly infected via percutaneous exposure to infected blood. Most persons with HCV were infected.
  • Injecting drug use is the most important risk factors nowadays
  • Transfusion of blood and blood products, especially before 1992
  • Unsafe therapeutic injections, especially in hemophilia patients prior to 1987

Other, less important risk factors include:[1][2]

  • Hemodialysis (Higher rates of infection are observed)
  • Solid organ transplantation from infected donors
  • Occupational exposure to blood, such as contaminated needle sticks
  • Birth to infected mother in cases of detectable maternal HCV PCR at delivery (at the rate of 4%–5%). Breastfeeding is not associated with the transmission.
  • Sexual intercourse with infected partner
  • Sexual intercourse with multiple partners
  • HIV infection
  • Tattoo or piercing with infected needle sticks (low risk for transmission after strict infection control measures)

References

  1. 1.0 1.1 Alter MJ (2007). "Epidemiology of hepatitis C virus infection". World J Gastroenterol. 13 (17): 2436–41. PMID 17552026.
  2. 2.0 2.1 Kaplan, David E. (2020). "Hepatitis C Virus". Annals of Internal Medicine. 173 (5): ITC33–ITC48. doi:10.7326/AITC202009010. ISSN 0003-4819.